Program

Home

Prostate Cancer

Eric A. Klein, MD is the Andrew C. Novick Chair of the Glickman Urological and Kidney Institute and Professor of Surgery in the Lerner College of Medicine of the Cleveland Clinic. Following fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center, he joined the staff of the Cleveland Clinic in 1989 and currently serves as a member of the Department of Cancer Biology

of the Cleveland Clinic Lerner Research Institute and Taussig Cancer Institute, and is Co-Director of the Genitourinary Malignancies Program in the Case Comprehensive Cancer Center.

Dr. Klein’s clinical and research interests have centered on the biology, prevention and management of prostate cancer, and most recently on the discovery and characterization of XMRV, for which he and Robert Silverman, PhD were granted the F. Mason Sones Innovation Award in 2009. DR. Klein has served as Chairman of the Localized Prostate Cancer Committee of the Southwest Oncology Group and is the National Study Coordinator for the NCI-sponsored Selenium and Vitamin E Cancer Prevention Trial (SELECT). He has contributed more than 300 papers to the scientific literature,  authored or edited 7 books on urologic malignancies, and serves as the Editor-in-Chief of Urology.